Clinical trial
Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus
NCT00393263 · Center for Vulvovaginal Disorders, Other · Completed
Key facts
| NCT number | NCT00393263 |
|---|---|
| Title | Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus |
| Official title | A Double-Blind, Parallel-group Trial of Topical Pimecrolimus Cream 1% (Elidel®) Versus Clobetasol 0.05% Cream for the Treatment of Vulvar Lichen Sclerosus |
| Lead sponsor | Center for Vulvovaginal Disorders, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lichen Sclerosus |
| Intervention type | Drug |
| Interventions | pimecrolimus and clobetasol, clobetasol 0.05% cream |
| Enrollment | 38 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Oct 27, 2006 |
| Last update posted | May 12, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: